Seeing Is Believing
Currently out of the existing stock ratings of Simos Simeonidis, 40 are a BUY (64.52%), 22 are a HOLD (35.48%).
Analyst Simos Simeonidis, carries an average stock price target met ratio of 73.33% that have a potential upside of 44.69% achieved within 402 days. Previously, Simos Simeonidis worked at RBC.
Simos Simeonidis’s has documented 99 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PBYI, Puma Biotechnology at 05-Jun-2017.
Analyst best performing recommendations are on DVAX (DYNAVAX TECHNOLOGIES).
The best stock recommendation documented was for DVAX (DYNAVAX TECHNOLOGIES) at 4/27/2016. The price target of $17 was fulfilled within 2 days with a profit of $1.53 (8.26%) receiving and performance score of 41.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$205
$22.5 (12.33%)
4 years 5 months 13 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 5 months 15 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 5 months 22 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy
$175
$-7.5 (-4.11%)
$165
4 years 8 months 14 days ago
(03-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold
$166
$-16.5 (-9.04%)
$175
4 years 8 months 14 days ago
(03-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
What Year was the first public recommendation made by Simos Simeonidis?